Art Rastinehad, DO, professor of urology and radiology, vice chair of urology at Northwell's Lenox Hill Hospital, and Northwell Health System director for prostate cancer, has been named a 2026 Castle Connolly Top Doctor. This marks the 12th year he has received this designation. Only 7 percent of the nation's licensed physicians are chosen annually as Castle Connolly Top Doctors for their specialties in their regions.
Dr. Rastinehad's clinical and research work focuses on precision prostate cancer diagnosis, MRI-targeted biopsy, focal therapy, image-guided treatment, interventional urology, and prostate artery embolization for enlarged prostate or benign prostatic hyperplasia (BPH). His approach emphasizes individualized care, coordinating the right evaluation and treatment options for each patient. "Every patient deserves a careful review of his PSA history, MRI findings, biopsy results, prostate size, urinary symptoms, cancer risk, and personal goals before choosing a treatment path," Dr. Rastinehad stated. "Precision prostate care means matching the right patient to the right diagnosis and the right treatment — not taking a one-size-fits-all approach."
Dr. Rastinehad's research team contributed to early validation of MR/US fusion biopsy for prostate cancer detection in the United States and continues to advance prostate cancer diagnosis, focal therapy planning, minimally invasive treatment, and interventional options for men with BPH. He was the first dual fellowship-trained urologic oncologist and interventional radiologist, completing advanced training through the National Institutes of Health, the National Cancer Institute, and Northwell's North Shore University Hospital.
Key achievements include being part of the first team to publish a series on prostate artery embolization in 2006, early validation of MR/US fusion biopsy, and serving as principal investigator in the development and clinical use of UroNav/Philips MR/US fusion technology for prostate biopsy and focal therapy planning. He is also a founding executive board member of the Focal Therapy Society and has over 20 years of experience in prostate artery embolization and interventional urology.
Dr. Rastinehad practices at the urology department at Lenox Hill Hospital, providing advanced prostate care for men with elevated PSA, abnormal prostate MRI, localized prostate cancer, enlarged prostate/BPH, urinary symptoms, and complex prostate treatment decisions.
Castle Connolly Top Doctors are nominated by peer physicians and selected by the physician-led Castle Connolly research team. Nominations are open to all board-certified MDs, DOs, and DPMs. The selection process considers medical education, training, hospital appointments, and disciplinary histories. Doctors do not and cannot pay to be selected. More information is available at castleconnolly.com.
